These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Passive reporting greatly underestimates the rate of transfusion-associated circulatory overload after platelet transfusion. Raval JS; Mazepa MA; Russell SL; Immel CC; Whinna HC; Park YA Vox Sang; 2015 May; 108(4):387-92. PubMed ID: 25753261 [TBL] [Abstract][Full Text] [Related]
43. A retrospective review of patient factors, transfusion practices, and outcomes in patients with transfusion-associated circulatory overload. Lieberman L; Maskens C; Cserti-Gazdewich C; Hansen M; Lin Y; Pendergrast J; Yi QL; Callum J Transfus Med Rev; 2013 Oct; 27(4):206-12. PubMed ID: 24075097 [TBL] [Abstract][Full Text] [Related]
44. Series of errors leading to life-threatening transfusion-associated circulatory overload. Czempik PF; Pluta M; Czajka S Anaesthesiol Intensive Ther; 2023; 55(2):120-122. PubMed ID: 37409835 [No Abstract] [Full Text] [Related]
45. Prophylactic furosemide to prevent transfusion-associated circulatory overload: a randomized controlled study in rats. Klanderman RB; Bosboom JJ; Veelo DP; Roelofs JJTH; de Korte D; van Bruggen R; Vogt L; van Buul JD; Hollmann MW; Vroom MB; Juffermans NP; Geerts BF; Vlaar APJ Sci Rep; 2022 Jul; 12(1):12127. PubMed ID: 35840620 [TBL] [Abstract][Full Text] [Related]
56. Risk factors and outcomes in transfusion-associated circulatory overload. Murphy EL; Kwaan N; Looney MR; Gajic O; Hubmayr RD; Gropper MA; Koenigsberg M; Wilson G; Matthay M; Bacchetti P; Toy P; Am J Med; 2013 Apr; 126(4):357.e29-38. PubMed ID: 23357450 [TBL] [Abstract][Full Text] [Related]
57. TACO-BEL-3: a feasibility study and a retrospective audit of diuretics for patients receiving blood transfusion at ten hospitals. Khandelwal A; Lin Y; Cserti-Gazdewich C; Al Moosawi M; Armali C; Arnold D; Callum J; Dallas KL; Lieberman L; Pavenski K; Rioux-Massé B; Shehata N; Shih AW; Pendergrast J Vox Sang; 2021 Apr; 116(4):434-439. PubMed ID: 33103789 [TBL] [Abstract][Full Text] [Related]
58. N-terminal pro-brain natriuretic peptide is a useful diagnostic marker for transfusion-associated circulatory overload. Tobian AA; Sokoll LJ; Tisch DJ; Ness PM; Shan H Transfusion; 2008 Jun; 48(6):1143-50. PubMed ID: 18298592 [TBL] [Abstract][Full Text] [Related]
59. Hemotherapy bedside biovigilance involving vital sign values and characteristics of patients with suspected transfusion reactions associated with fluid challenges: can some cases of transfusion-associated circulatory overload have proinflammatory aspects? Andrzejewski C; Popovsky MA; Stec TC; Provencher J; O'Hearn L; Visintainer P; Steingrub J Transfusion; 2012 Nov; 52(11):2310-20. PubMed ID: 23216230 [TBL] [Abstract][Full Text] [Related]
60. Transfusion-Associated Circulatory Overload in ICUs: A Scoping Review of Incidence, Risk Factors, and Outcomes. De Cloedt L; Savy N; Gauvin F; Taylor S; Lacroix J; Emeriaud G Crit Care Med; 2019 Jun; 47(6):849-856. PubMed ID: 30882480 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]